Literature DB >> 34521256

Current Understanding of Pathological Mechanisms of Lymphedema.

Cynthia Sung1,2, Sarah Wang3, Jerry Hsu2,3,4, Roy Yu1, Alex K Wong2,3.   

Abstract

Significance: Lymphedema is a common disease that affects hundreds of millions of people worldwide with significant financial and social burdens. Despite increasing prevalence and associated morbidities, the mainstay treatment of lymphedema is largely palliative without an effective cure due to incomplete understanding of the disease. Recent Advances: Recent studies have described key histological and pathological processes that contribute to the progression of lymphedema, including lymphatic stasis, inflammation, adipose tissue deposition, and fibrosis. This review aims to highlight cellular and molecular mechanisms involved in each of these pathological processes. Critical Issues: Despite recent advances in the understanding of the pathophysiology of lymphedema, cellular and molecular mechanisms underlying the disease remains elusive due to its complex nature. Future Directions: Additional research is needed to gain a better insight into the cellular and molecular mechanisms underlying the pathophysiology of lymphedema, which will guide the development of therapeutic strategies that target specific pathology of the disease.

Entities:  

Keywords:  adipose deposition; fibrosis; inflammation; lymphedema; pathophysiology

Mesh:

Year:  2021        PMID: 34521256      PMCID: PMC9051876          DOI: 10.1089/wound.2021.0041

Source DB:  PubMed          Journal:  Adv Wound Care (New Rochelle)        ISSN: 2162-1918            Impact factor:   4.947


  97 in total

1.  Expression of angiogenic and vasculogenic factors in human lymphedematous tissue.

Authors:  Rafael A Couto; Ann M Kulungowski; Aditya S Chawla; Steven J Fishman; Arin K Greene
Journal:  Lymphat Res Biol       Date:  2011       Impact factor: 2.589

Review 2.  Lymphedema: Pathophysiology and clinical manifestations.

Authors:  Ayman A Grada; Tania J Phillips
Journal:  J Am Acad Dermatol       Date:  2017-12       Impact factor: 11.527

3.  Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.

Authors:  T Veikkola; L Jussila; T Makinen; T Karpanen; M Jeltsch; T V Petrova; H Kubo; G Thurston; D M McDonald; M G Achen; S A Stacker; K Alitalo
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

4.  VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.

Authors:  Krista Heinolainen; Sinem Karaman; Gabriela D'Amico; Tuomas Tammela; Raija Sormunen; Lauri Eklund; Kari Alitalo; Georgia Zarkada
Journal:  Circ Res       Date:  2017-03-15       Impact factor: 17.367

5.  Pathological Changes of Lymphedematous Skin: Increased Mast Cells, Related Proteases, and Activated Transforming Growth Factor-β1.

Authors:  Sun Di; Yu Ziyou; Ning-Fei Liu
Journal:  Lymphat Res Biol       Date:  2016-09-06       Impact factor: 2.589

6.  T lymphocytes negatively regulate lymph node lymphatic vessel formation.

Authors:  Raghu P Kataru; Honsoul Kim; Cholsoon Jang; Dong Kyu Choi; Bong Ihn Koh; Minah Kim; Sudheer Gollamudi; Yun-Keun Kim; Seung-Hyo Lee; Gou Young Koh
Journal:  Immunity       Date:  2011-01-20       Impact factor: 31.745

7.  VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.

Authors:  Mikko T Visuri; Krista M Honkonen; Pauliina Hartiala; Tomi V Tervala; Paavo J Halonen; Heikki Junkkari; Nina Knuutinen; Seppo Ylä-Herttuala; Kari K Alitalo; Anne M Saarikko
Journal:  Angiogenesis       Date:  2015-05-28       Impact factor: 9.596

8.  TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair.

Authors:  Nicholas W Clavin; Tomer Avraham; John Fernandez; Sanjay V Daluvoy; Marc A Soares; Arif Chaudhry; Babak J Mehrara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-10       Impact factor: 4.733

Review 9.  A comprehensive overview on the surgical management of secondary lymphedema of the upper and lower extremities related to prior oncologic therapies.

Authors:  Ramon Garza; Roman Skoracki; Karen Hock; Stephen P Povoski
Journal:  BMC Cancer       Date:  2017-07-05       Impact factor: 4.430

10.  CD4+ T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema.

Authors:  Gabriela D García Nores; Catherine L Ly; Daniel A Cuzzone; Raghu P Kataru; Geoffrey E Hespe; Jeremy S Torrisi; Jung Ju Huang; Jason C Gardenier; Ira L Savetsky; Matthew D Nitti; Jessie Z Yu; Sonia Rehal; Babak J Mehrara
Journal:  Nat Commun       Date:  2018-05-17       Impact factor: 14.919

View more
  1 in total

1.  Recovery of Dysregulated Genes in Cancer-Related Lower Limb Lymphedema After Supermicrosurgical Lymphaticovenous Anastomosis - A Prospective Longitudinal Cohort Study.

Authors:  Johnson Chia-Shen Yang; Lien-Hung Huang; Shao-Chun Wu; Yi-Chan Wu; Chia-Jung Wu; Chia-Wei Lin; Pei-Yu Tsai; Peng-Chen Chien; Ching-Hua Hsieh
Journal:  J Inflamm Res       Date:  2022-02-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.